UPPSALA, Sweden, Dec. 13, 2018 /PRNewswire/ -- Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the Company will r...
Original Article: Orexo Regains Rights to Zubsolv in all Countries Outside the US